Diet has long been recognized as the primary treatment modality for individ
uals with phenylketonuria (PKU) during infancy and childhood. Recent findin
gs from the Maternal PKU Collaborative Study clearly indicate that dietary
restriction of phenylalanine is also necessary to prevent the adverse effec
ts of an elevated plasma phenylalanine concentration during pregnancy, whic
h include microcephaly, physical anomalies, and mental retardation.